Hemoglobin A1c Testing Devices Market Revenue to Attain USD 4.18 Bn by 2033

26 Jun 2025

Share :

Table of Content

1. Hemoglobin A1c Testing Devices Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Hemoglobin A1c Testing Devices Market? 3. Segment Insights 4. Regional Insights 5. Hemoglobin A1c Testing Devices Market Coverage 6. Hemoglobin A1C Testing Devices Market Key Players

Hemoglobin A1c Testing Devices Market Revenue and Trends 2025 to 2033

The global hemoglobin A1c testing devices market revenue was valued at USD 2.52 billion in 2025 and is expected to attain around USD 4.18 billion by 2033, growing at a CAGR of 6.52% during forecast period. This market is growing due to the global surge in diabetes prevalence and the rising demand for accurate blood glucose monitoring solutions for effective disease management.

What are the Major Factors Driving the Growth of the Hemoglobin A1c Testing Devices Market?

The hemoglobin A1c testing devices market is poised for rapid growth, mainly due to the rise in the number of diabetes cases across the globe. With changes in lifestyle and increased rates of obesity, the prevalence of diabetes is rising, leading to health concerns among people. The growing geriatric population is expected to drive the growth of the market, as older adults are more prone to diabetes, requiring routine monitoring of blood glucose level via the HbA1c test. They are the most reliable devices for long-term blood glucose monitoring. They help in managing and diagnosing type 1 diabetes and type 2 diabetes.

Ongoing advances in medical devices and point-of-care testing devices are likely to open up new growth avenues for the market. Innovations like portable analyzers that are easy to use enable accurate testing and availability outside of practice-based testing. The growing interest in preventive healthcare and government support of chronic disease screening is expected to drive the growth of the market. With the increased emphasis on personalized treatment, health care professionals are relying more and more on HbA1c testing devices to recommend therapy changes, which drive market growth.

Segment Insights

• By type of device, the point-of-care testing devices segment contributed the largest market share in 2024 due to the increased need for rapid diagnosis for immediate intervention. These devices allow for rapid turnaround times, providing actionable results that help in immediate treatment. They are widely preferred for their portability, ease of use, and accuracy in monitoring diabetes.
• By technology, the immunoassays segment dominated the market in 2024 due to their high accuracy, low cost, and established clinical diagnostic use in diabetes management and long-term monitoring.
• By end-user, the hospitals & clinics segment held a major revenue share in 2024 due to the increased patient footfall undergoing diabetes management. Hospitals and clinics often offer comprehensive care, making them a central location for diabetes management.

Regional Insights

North America registered dominance in the hemoglobin A1c testing devices market in 2024. This is mainly due to an aging population, leading to increased prevalence of diabetes, especially in countries like the U.S. and Canada. Advanced healthcare infrastructure, high demand for personalized care, and rising development of sophisticated medical devices support regional market growth.

Meanwhile, Asia Pacific is emerging as the fastest-growing region in the market, driven by growing rates of diabetes, increasing healthcare expenditure, and a strong focus on patient-centric care. Continuous improvements in healthcare infrastructure, especially in countries like China, India, and Japan, further support market growth. Moreover, the rapid shift toward home-based care is boosting the demand for Hb A1c testing devices.

Hemoglobin A1c Testing Devices Market Coverage

Recent Development

• In February 2023, Hurdle announced the general availability of the Hemoglobin A1c (HbA1c) Test1. The new test enables adult consumers to take a simple at-home blood sample to screen and monitor diabetes.
  (Source: https://www.globenewswire.com)

Hemoglobin A1C Testing Devices Market Key Players

• Bio-Rad Laboratories, Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• HUMAN
• Trinity Biotech
• Menarini Diagnostics s.r.l
• SAKAE CO., LTD.
• Ceragem Medisys Inc
• SEKISUI MEDICAL CO., LTD.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6287

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344